{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T17:31:29Z","timestamp":1772559089049,"version":"3.50.1"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:00:00Z","timestamp":1762646400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020220","name":"College of Science, University of Arizona","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["K24AI143447"],"award-info":[{"award-number":["K24AI143447"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R21AI167027"],"award-info":[{"award-number":["R21AI167027"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019317","name":"Utah Valley University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry Reports"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.ejmcr.2025.100311","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T10:33:38Z","timestamp":1763030018000},"page":"100311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Discovery of highly potent \u03b1-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of Mycobacterium tuberculosis"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6165-9066","authenticated-orcid":false,"given":"Nicholas","family":"Schumann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah","family":"Shamma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6745-6526","authenticated-orcid":false,"given":"Cory L.","family":"Brooks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7992-2494","authenticated-orcid":false,"given":"Sean J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew K.","family":"Yim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith J.","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1338-9206","authenticated-orcid":false,"given":"Petros C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Abell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4053-4037","authenticated-orcid":false,"given":"Nathan E.","family":"Goldfarb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmcr.2025.100311_bib1","series-title":"Global Tuberculosis Report 2024","year":"2024"},{"key":"10.1016\/j.ejmcr.2025.100311_bib2","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/814943","article-title":"Pathogenesis, immunology, and diagnosis of latent Mycobacterium tuberculosis infection","volume":"2011","author":"Ahmad","year":"2011","journal-title":"Clin. Dev. Immunol."},{"issue":"10","key":"10.1016\/j.ejmcr.2025.100311_bib3","doi-asserted-by":"crossref","first-page":"6272","DOI":"10.4049\/jimmunol.172.10.6272","article-title":"Mycobacterium tuberculosis inhibits macrophage responses to IFN-gamma through myeloid differentiation factor 88-dependent and -independent mechanisms","volume":"172","author":"Fortune","year":"2004","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ejmcr.2025.100311_bib4","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.4049\/jimmunol.173.4.2660","article-title":"Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing","volume":"173","author":"Gehring","year":"2004","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.ejmcr.2025.100311_bib5","doi-asserted-by":"crossref","first-page":"4487","DOI":"10.1128\/IAI.71.8.4487-4497.2003","article-title":"The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through toll-like receptor 2","volume":"71","author":"Gehring","year":"2003","journal-title":"Infect. Immun."},{"issue":"3","key":"10.1016\/j.ejmcr.2025.100311_bib6","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1073\/pnas.022649799","article-title":"Human macrophage activation programs induced by bacterial pathogens","volume":"99","author":"Nau","year":"2001","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"11","key":"10.1016\/j.ejmcr.2025.100311_bib7","doi-asserted-by":"crossref","first-page":"6603","DOI":"10.1128\/IAI.72.11.6603-6614.2004","article-title":"Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages","volume":"72","author":"Pai","year":"2004","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.ejmcr.2025.100311_bib8","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ni1468","article-title":"Direct extracellular interaction between the early secreted antigen ESAT-6 of Mycobacterium tuberculosis and TLR2 inhibits TLR signaling in macrophages","volume":"8","author":"Pathak","year":"2007","journal-title":"Nat. Immunol."},{"issue":"3","key":"10.1016\/j.ejmcr.2025.100311_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1128\/MMBR.00010-14","article-title":"Latent tuberculosis infection: myths, models, and molecular mechanisms","volume":"78","author":"Dutta","year":"2014","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmcr.2025.100311_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.744167","article-title":"Targeting the Mycobacterium tuberculosis stringent response as a strategy for shortening tuberculosis treatment","volume":"12","author":"Danchik","year":"2021","journal-title":"Front. Microbiol."},{"issue":"8","key":"10.1016\/j.ejmcr.2025.100311_bib11","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.4155\/fmc.10.214","article-title":"New strategies in fighting TB: targeting mycobacterium tuberculosis-secreted phosphatases MptpA & MptpB","volume":"2","author":"Silva","year":"2010","journal-title":"Future Med. Chem."},{"issue":"18","key":"10.1016\/j.ejmcr.2025.100311_bib12","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1021\/acs.jmedchem.8b00832","article-title":"Structure-based design of MptpB inhibitors that reduce multidrug-resistant Mycobacterium tuberculosis survival and infection burden in vivo","volume":"61","author":"Vickers","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmcr.2025.100311_bib13","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.omtn.2022.02.011","article-title":"The Mycobacterium tuberculosis PhoPR virulence system regulates expression of the universal second messenger c-di-AMP and impacts vaccine safety and efficacy","volume":"27","author":"Perez","year":"2022","journal-title":"Mol. Ther. Nucleic Acids"},{"issue":"8","key":"10.1016\/j.ejmcr.2025.100311_bib14","doi-asserted-by":"crossref","first-page":"4436","DOI":"10.1128\/AAC.00719-15","article-title":"The carbonic anhydrase inhibitor ethoxzolamide inhibits the Mycobacterium tuberculosis PhoPR regulon and Esx-1 secretion and attenuates virulence","volume":"59","author":"Johnson","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"issue":"7","key":"10.1016\/j.ejmcr.2025.100311_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/nrd.2017.23","article-title":"Different drugs for bad bugs: antivirulence strategies in the age of antibiotic resistance","volume":"16","author":"Dickey","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"25","key":"10.1016\/j.ejmcr.2025.100311_bib16","doi-asserted-by":"crossref","first-page":"18348","DOI":"10.1074\/jbc.M700035200","article-title":"Characterization of a novel cell wall-anchored protein with carboxylesterase activity required for virulence in Mycobacterium tuberculosis","volume":"282","author":"Lun","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.ejmcr.2025.100311_bib17","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1128\/IAI.05574-11","article-title":"Mycobacterium tuberculosis Hip1 dampens macrophage proinflammatory responses by limiting toll-like receptor 2 activation","volume":"79","author":"Madan-Lala","year":"2011","journal-title":"Infect. Immun."},{"issue":"6","key":"10.1016\/j.ejmcr.2025.100311_bib18","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/IAI.70.6.2787-2795.2002","article-title":"Mycobacterium tuberculosis genes induced during infection of human macrophages","volume":"70","author":"Dubnau","year":"2002","journal-title":"Infect. Immun."},{"issue":"23","key":"10.1016\/j.ejmcr.2025.100311_bib19","doi-asserted-by":"crossref","first-page":"8327","DOI":"10.1073\/pnas.0503272102","article-title":"Genome-wide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages","volume":"102","author":"Rengarajan","year":"2005","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.ejmcr.2025.100311_bib20","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1073\/pnas.0710601105","article-title":"Mycobacterium tuberculosis Rv2224c modulates innate immune responses","volume":"105","author":"Rengarajan","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.ejmcr.2025.100311_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004132","article-title":"Mycobacterium tuberculosis Hip1 modulates macrophage responses through proteolysis of GroEL2","volume":"10","author":"Naffin-Olivos","year":"2014","journal-title":"PLoS Pathog."},{"issue":"8","key":"10.1016\/j.ejmcr.2025.100311_bib22","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm.1795","article-title":"A membrane protein preserves intrabacterial pH in intraphagosomal Mycobacterium tuberculosis","volume":"14","author":"Vandal","year":"2008","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ejmcr.2025.100311_bib23","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JB.00932-08","article-title":"Acid-susceptible mutants of Mycobacterium tuberculosis share hypersusceptibility to cell wall and oxidative stress and to the host environment","volume":"191","author":"Vandal","year":"2009","journal-title":"J. Bacteriol."},{"issue":"9","key":"10.1016\/j.ejmcr.2025.100311_bib24","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.3390\/microorganisms11092269","article-title":"Functional whole genome screen of nutrient-starved Mycobacterium tuberculosis identifies genes involved in rifampin tolerance","volume":"11","author":"Matern","year":"2023","journal-title":"Microorganisms"},{"issue":"12","key":"10.1016\/j.ejmcr.2025.100311_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01334-17","article-title":"Chemical genetic interaction profiling reveals determinants of intrinsic antibiotic resistance in Mycobacterium tuberculosis","volume":"61","author":"Xu","year":"2017","journal-title":"Antimicrob. Agents Chemother."},{"issue":"13","key":"10.1016\/j.ejmcr.2025.100311_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310482","article-title":"Target identification in anti-tuberculosis drug discovery","volume":"24","author":"Capela","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejmcr.2025.100311_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1128\/AAC.2.1.29","article-title":"Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis","volume":"2","author":"Takayama","year":"1972","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6496","key":"10.1016\/j.ejmcr.2025.100311_bib28","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.aba9102","article-title":"Structures of cell wall arabinosyltransferases with the anti-tuberculosis drug ethambutol","volume":"368","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.ejmcr.2025.100311_bib29","article-title":"Re-Understanding the mechanisms of action of the anti-mycobacterial drug bedaquiline","volume":"8","author":"Sarathy","year":"2019","journal-title":"Antibiotics (Basel)"},{"issue":"1","key":"10.1016\/j.ejmcr.2025.100311_bib30","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1099\/00221287-63-1-41","article-title":"Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis","volume":"63","author":"Winder","year":"1970","journal-title":"J. Gen. Microbiol."},{"issue":"17","key":"10.1016\/j.ejmcr.2025.100311_bib31","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1021\/acs.biochem.6b01066","article-title":"Structure determination of Mycobacterium tuberculosis serine protease Hip1 (Rv2224c)","volume":"56","author":"Naffin-Olivos","year":"2017","journal-title":"Biochemistry"},{"issue":"11","key":"10.1016\/j.ejmcr.2025.100311_bib32","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1021\/acsinfecdis.6b00092","article-title":"Design of selective substrates and activity-based probes for hydrolase important for pathogenesis 1 (HIP1) from Mycobacterium tuberculosis","volume":"2","author":"Lentz","year":"2016","journal-title":"ACS Infect. Dis."},{"issue":"2","key":"10.1016\/j.ejmcr.2025.100311_bib33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0006-291X(67)80055-X","article-title":"On the size of the active site in proteases. I. Papain","volume":"27","author":"Schechter","year":"1967","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6575","key":"10.1016\/j.ejmcr.2025.100311_bib34","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abl4784","article-title":"An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19","volume":"374","author":"Owen","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.ejmcr.2025.100311_bib35","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1021\/jm9805384","article-title":"Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-Glutamine replacements","volume":"42","author":"Dragovich","year":"1999","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmcr.2025.100311_bib36","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0968-0896(99)00005-X","article-title":"Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: optimization of tripeptides incorporating N-terminal amides","volume":"7","author":"Dragovich","year":"1999","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmcr.2025.100311_bib37","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/0968-0896(95)00104-O","article-title":"Thrombin active site inhibitors","volume":"3","author":"Das","year":"1995","journal-title":"Bioorg. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmcr.2025.100311_bib38","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/med.2610140202","article-title":"Synthetic inhibitors of elastase","volume":"14","author":"Edwards","year":"1994","journal-title":"Med. Res. Rev."},{"issue":"9","key":"10.1016\/j.ejmcr.2025.100311_bib39","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nrd3053","article-title":"Emerging principles in protease-based drug discovery","volume":"9","author":"Drag","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmcr.2025.100311_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2174\/187152606776056706","article-title":"Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3\u20224A serine protease","volume":"6","author":"Lin","year":"2006","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.ejmcr.2025.100311_bib41","doi-asserted-by":"crossref","first-page":"6074","DOI":"10.1021\/jm060325b","volume":"49","author":"Venkatraman","year":"2006","journal-title":"J. Med. Chem."},{"issue":"21","key":"10.1016\/j.ejmcr.2025.100311_bib42","doi-asserted-by":"crossref","first-page":"12725","DOI":"10.1021\/acs.jmedchem.0c01063","article-title":"Discovery of ketone-based covalent inhibitors of coronavirus 3CL proteases for the potential therapeutic treatment of COVID-19","volume":"63","author":"Hoffman","year":"2020","journal-title":"J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmcr.2025.100311_bib43","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1021\/acs.jmedchem.9b01828","article-title":"alpha-Ketoamides as broad-spectrum inhibitors of coronavirus and enterovirus replication: structure-based design, synthesis, and activity assessment","volume":"63","author":"Zhang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmcr.2025.100311_bib44","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1016\/S0040-4039(98)01504-4","article-title":"Synthesis of cyanoketophosphoranes, precursors of [3-Amino-c\u223c-keto-esters from UNCAs","volume":"39","author":"Paris l","year":"1998","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmcr.2025.100311_bib45","doi-asserted-by":"crossref","first-page":"4364","DOI":"10.1021\/jo00095a005","article-title":"(Cyanomethylene)phosphoranes as novel carbonyl 1,1-Dipole synthons: an efficient synthesis of -Keto acids, esters, and amides","volume":"59","author":"Wasserman","year":"1994","journal-title":"J. Org. Chem."},{"issue":"22","key":"10.1016\/j.ejmcr.2025.100311_bib46","doi-asserted-by":"crossref","first-page":"9564","DOI":"10.1021\/jm501357r","article-title":"Synthesis and evaluation of radioiodinated acyloxymethyl ketones as activity-based probes for cathepsin B","volume":"57","author":"Edem","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmcr.2025.100311_bib47","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.bbrc.2022.09.021","article-title":"2.1 A crystal structure of the Mycobacterium tuberculosis serine hydrolase, Hip1, in its anhydro-form (Anhydrohip1)","volume":"630","author":"Brooks","year":"2022","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmcr.2025.100311_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1021\/jm00163a002","article-title":"alpha.-diketone and .alpha.-keto ester derivatives of N-protected amino acids and peptides as novel inhibitors of cysteine and serine proteinases","volume":"33","author":"Angelastro","year":"1990","journal-title":"J. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmcr.2025.100311_bib49","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1021\/jm00074a031","article-title":"Peptide -Keto ester, -Keto amide, and -Keto acid inhibitors of calpains and other cysteine proteases","volume":"36","author":"Li","year":"1993","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmcr.2025.100311_bib50","article-title":"Autoluminescent Mycobacterium tuberculosis for rapid, real-time, non-invasive assessment of drug and vaccine efficacy","volume":"7","author":"Zhang","year":"2012","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.ejmcr.2025.100311_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002251","article-title":"High-resolution phenotypic profiling defines genes essential for mycobacterial growth and cholesterol catabolism","volume":"7","author":"Griffin","year":"2011","journal-title":"PLoS Pathog."},{"issue":"4","key":"10.1016\/j.ejmcr.2025.100311_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mSystems.00070-19","article-title":"Genomewide assessment of Mycobacterium tuberculosis conditionally essential metabolic pathways","volume":"4","author":"Minato","year":"2019","journal-title":"mSystems"},{"issue":"1","key":"10.1016\/j.ejmcr.2025.100311_bib53","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2472555217732289","article-title":"A high-throughput screening triage workflow to authenticate a novel series of PFKFB3 inhibitors","volume":"23","author":"St-Gallay","year":"2018","journal-title":"SLAS Discov."},{"issue":"1","key":"10.1016\/j.ejmcr.2025.100311_bib54","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s12154-009-0029-3","article-title":"Hill coefficients, dose-response curves and allosteric mechanisms","volume":"3","author":"Prinz","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.ejmcr.2025.100311_bib55","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cell.2010.07.015","article-title":"Structural basis for negative cooperativity in growth factor binding to an EGF receptor","volume":"142","author":"Alvarado","year":"2010","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.ejmcr.2025.100311_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104305","article-title":"Mycobacterium tuberculosis impedes CD40-dependent notch signaling to restrict Th(17) polarization during infection","volume":"25","author":"Enriquez","year":"2022","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.ejmcr.2025.100311_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0005-2744(69)90420-3","article-title":"Kinetics of the reversible inhibition of enzyme-catalysed reactions by tight-binding inhibitors","volume":"185","author":"Morrison","year":"1969","journal-title":"Biochim. Biophys. Acta"}],"container-title":["European Journal of Medicinal Chemistry Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772417425000676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772417425000676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T16:20:18Z","timestamp":1772554818000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772417425000676"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":57,"alternative-id":["S2772417425000676"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmcr.2025.100311","relation":{},"ISSN":["2772-4174"],"issn-type":[{"value":"2772-4174","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of highly potent \u03b1-keto ester-based peptidomimetic inhibitors of the Hip1 protease for the treatment of Mycobacterium tuberculosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmcr.2025.100311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"100311"}}